NEW: Premarket Now Starts at 4AM!

We’re excited to announce the extension of premarket and aftermarket hours! Our members now have access to quotes daily from 4:00 AM to 8:00 PM ET — offering greater flexibility and deeper insights into market trends beyond regular trading hours.

Upgrade to FINVIZ*Elite to access premarket quotes »

SLDB

Solid Biosciences Inc

May 23 • 04:00PM ET

2.81

Dollar change -0.08
Percentage change -2.77	%

Healthcare • Biotechnology • USA • NASD

Peers: SRPT PFE BMRN BLUE QURE EDIT RGEN NTLA ABEO VYGR

| Held by: VTI IWM IBB VXF IWN VTWO IWC DFAS DFAT PRFZ

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-2.99	Insider Own	27.40%	Shs Outstand	77.49M	Perf Week	1.44%
Market Cap	217.82M	Forward P/E	-	EPS next Y	-2.14	Insider Trans	41.18%	Shs Float	56.28M	Perf Month	-23.43%
Income	-139.68M	PEG	-	EPS next Q	-0.50	Inst Own	77.16%	Short Float	12.60%	Perf Quarter	-49.64%
Sales	0.00M	P/S	-	EPS this Y	30.03%	Inst Trans	42.68%	Short Ratio	4.76	Perf Half Y	-45.01%
Book/sh	3.80	P/B	0.74	EPS next Y	0.12%	ROA	-47.14%	Short Interest	7.09M	Perf Year	-66.98%
Cash/sh	3.96	P/C	0.71	EPS next 5Y	16.97%	ROE	-55.30%	52W Range	2.41 - 10.37	Perf YTD	-29.75%
Dividend Est.	-	P/FCF	-	EPS past 5Y	41.25%	ROI	-44.32%	52W High	-72.90%	Beta	2.21
Dividend TTM	-	Quick Ratio	10.89	Sales past 5Y	-28.11%	Gross Margin	-	52W Low	16.60%	ATR (14)	0.35
Dividend Ex-Date	-	Current Ratio	10.89	EPS Y/Y TTM	23.93%	Oper. Margin	-	RSI (14)	45.12	Volatility	6.66% 10.38%
Employees	100	Debt/Eq	0.08	Sales Y/Y TTM	-100.00%	Profit Margin	-	Recom	1.08	Target Price	16.10
Option/Short	Yes / Yes	LT Debt/Eq	0.07	EPS Q/Q	7.05%	Payout	-	Rel Volume	0.59	Prev Close	2.89
Sales Surprise	-	EPS Surprise	-6.27%	Sales Q/Q	-	Earnings	May 15 AMC	Avg Volume	1.49M	Price	2.81
SMA20	-8.05%	SMA50	-18.02%	SMA200	-45.69%	Trades		Volume	871,960	Change	-2.77%

Date	Action	Analyst	Rating Change	Price Target Change
Jan-08-25	Initiated	Truist	Buy	$16
Dec-13-24	Initiated	Wedbush	Outperform	$16
Dec-10-24	Initiated	JMP Securities	Mkt Outperform	$15
Jul-15-24	Upgrade	JP Morgan	Neutral → Overweight	$10 → $15
Jun-24-24	Upgrade	Leerink Partners	Market Perform → Outperform	$12
May-31-24	Resumed	Piper Sandler	Overweight	$20
Mar-28-24	Initiated	William Blair	Outperform	$40
Mar-15-24	Initiated	Citigroup	Buy	$16
Mar-14-24	Upgrade	Piper Sandler	Neutral → Overweight	$8 → $20
Dec-08-23	Initiated	H.C. Wainwright	Buy	$9
Jul-12-21	Initiated	Piper Sandler	Neutral	$6
May-27-21	Initiated	Jefferies	Buy	$7
Mar-16-21	Upgrade	SVB Leerink	Mkt Perform → Outperform	$3 → $15
Mar-09-21	Initiated	Barclays	Overweight	$13
Jan-08-21	Upgrade	Credit Suisse	Underperform → Neutral	$2 → $7
Jul-28-20	Downgrade	SVB Leerink	Outperform → Mkt Perform
May-07-20	Downgrade	Evercore ISI	Outperform → In-line
Oct-11-19	Initiated	Evercore ISI	Outperform	$22
Aug-29-19	Downgrade	Citigroup	Neutral → Sell	$6
Aug-19-19	Upgrade	SVB Leerink	Mkt Perform → Outperform	$8 → $15

Show Previous Ratings

May-15-25 04:06PM	Solid Biosciences Reports First Quarter 2025 Financial Results and Provides Business Updates (GlobeNewswire) +6.95%
May-01-25 04:00PM	Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) +10.27% +18.08%
Apr-30-25 08:00AM	Solid Biosciences to Participate at The Citizens Life Sciences Conference (GlobeNewswire) +8.52%
Apr-29-25 08:00AM	Solid Biosciences to Present at the American Society of Gene and Cell Therapy's 28th Annual Meeting (GlobeNewswire) -5.57%
Apr-08-25 04:50PM	Solid Biosciences: A Strong Buy As An Emerging Biotech In The Gene Therapy Space (Seeking Alpha) -9.18%
07:30AM	Loading…
07:30AM	Can Solid Biosciences Challenge Sarepta in the DMD Market? (MarketBeat)
Apr-07-25 08:00AM	Solid Biosciences to Participate at Upcoming Investor Conferences (GlobeNewswire) -5.62%
Apr-01-25 08:00AM	Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) -6.89%
07:00AM	Climb Bio Appoints Seasoned Biotech Leaders to Board of Directors (GlobeNewswire)
Mar-26-25 12:31PM	5 Reasons To Buy Regenxbio Right Now (SeekingAlpha) -5.12%
Mar-14-25 10:29PM	Solid Biosciences Inc. (SLDB): Among Top Insider Purchases Last Month (Insider Monkey) +5.30%
Mar-12-25 08:00AM	Solid Biosciences to Present at the 2025 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference (GlobeNewswire)
Mar-07-25 09:55AM	Wall Street Analysts Believe Solid Biosciences (SLDB) Could Rally 198.18%: Here's is How to Trade (Zacks)
Mar-06-25 04:16PM	Solid Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Updates (GlobeNewswire)
Mar-05-25 08:00AM	Solid Biosciences to Participate at Upcoming Investor Conferences (GlobeNewswire) +8.47%
08:33PM	Loading…
Mar-04-25 08:33PM	Is Solid Biosciences Inc. (SLDB) Among Stocks With At Least $20 Million In Insider Spending Recently? (Insider Monkey)
04:07PM	Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Feb-19-25 08:02AM	Solid Biosciences stock soars on early success in DMD gene therapy trial (Clinical Trials Arena) +22.08%
Feb-18-25 07:00AM	Solid Biosciences Announces Pricing of Underwritten Offering (GlobeNewswire) +31.51%
06:45AM	Solid Biosciences Reports Positive Initial Clinical Data from Next-Generation Duchenne Gene Therapy Candidate SGT-003 (GlobeNewswire)
06:36AM	Solid says early data suggest differentiated Duchenne gene therapy (BioPharma Dive)
Feb-09-25 06:12AM	Analysts Predict Up to ~450% Surge for These 2 Strong Buy Penny Stocks (TipRanks)
Feb-04-25 08:00AM	Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Jan-21-25 08:30AM	Solid Biosciences Receives FDA Fast Track Designation for SGT-212 Dual Route of Administration Gene Therapy for Friedreich's Ataxia (GlobeNewswire)
Jan-15-25 04:05PM	Solid Biosciences Outlines Key Priorities for Advancing Diversified Neuromuscular and Cardiac Development Pipeline and Establishing Leadership in Precision Genetic Medicines (GlobeNewswire)
Jan-08-25 04:05PM	Solid Biosciences to Present at the 43rd Annual J.P. Morgan Healthcare Conference (GlobeNewswire) -8.68%
Jan-07-25 04:15PM	Solid Biosciences Announces FDA IND Clearance for First-In-Industry Dual Route of Administration Gene Therapy to Treat Both Neurologic and Cardiac Manifestations of Friedreich's Ataxia (GlobeNewswire)
Jan-06-25 08:00AM	Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Dec-23-24 04:05PM	Solid Biosciences Added to the Nasdaq Biotechnology Index (GlobeNewswire)
Dec-13-24 01:52PM	Solid Biosciences Positioned For Next-Gen Duchenne Muscular Dystrophy Treatment Success: Analyst (Benzinga)
08:05AM	Loading…
Dec-04-24 08:05AM	Solid Biosciences reports inducement grant under Nasdaq listing rule (TipRanks)
08:00AM	Solid Biosciences Announces Collaboration with Mayo Clinic to Accelerate Gene Therapy Innovation and Advance Development of Cardiac Gene Therapies (GlobeNewswire)
Dec-03-24 08:00AM	Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) -10.54%
Nov-26-24 08:00AM	Solid Biosciences to Participate at Upcoming Investor Conferences (GlobeNewswire)
Nov-14-24 08:00AM	Solid Biosciences to Present at the Jefferies London Healthcare Conference (GlobeNewswire)
Nov-06-24 04:05PM	Solid Biosciences Reports Third Quarter 2024 Financial Results and Provides Business Updates (GlobeNewswire) -6.03%
Nov-04-24 08:00AM	Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Oct-31-24 08:00AM	Solid Biosciences to Participate at the Truist Securities BioPharma Symposium (GlobeNewswire)
Oct-02-24 04:15PM	Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Sep-23-24 08:00AM	Solid Biosciences to Participate at Chardan's 8th Annual Genetic Medicines Conference (GlobeNewswire)
Sep-12-24 08:00AM	Solid Biosciences to Participate at the 2024 Cantor Global Healthcare Conference (GlobeNewswire)
Sep-04-24 04:05PM	Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
08:00AM	Solid Biosciences to Participate at Upcoming Investor Conferences (GlobeNewswire)
Aug-13-24 04:08PM	Solid Biosciences Reports Second Quarter 2024 Financial Results and Provides Business Updates (GlobeNewswire) +14.54%
Aug-05-24 08:00AM	Solid Biosciences Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Jul-01-24 04:19PM	Solid Biosciences Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) +10.58%
08:00AM	Solid Biosciences Joins the Russell 3000 Index (GlobeNewswire)
Jun-21-24 07:52AM	Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday (InvestorPlace)
Jun-04-24 04:00PM	Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
May-20-24 06:00AM	3 Must-Buy Biotech Stocks Before the Summer Rally Kicks Off (InvestorPlace)
May-15-24 12:53PM	SLDB Stock Earnings: Solid Biosciences Meets EPS for Q1 2024 (InvestorPlace)
07:52AM	Solid Biosciences Provides First Quarter 2024 Business Update and Financial Results (GlobeNewswire)
May-07-24 07:00AM	Solid Biosciences to Present at the American Society of Gene and Cell Therapy Annual Meeting (GlobeNewswire)
May-02-24 04:05PM	Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) +7.23%
Apr-03-24 04:05PM	Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Apr-02-24 10:35AM	Solid Biosciences (SLDB) Falls Despite FDA Rare Tag for DMD Drug (Zacks)
07:20AM	Solid Biosciences' SGT-003 receives rare pediatric disease designation (Pharmaceutical Business Review)
Apr-01-24 07:45AM	Solid Biosciences Receives Rare Pediatric Disease Designation from the FDA for Duchenne Muscular Dystrophy Gene Therapy Candidate SGT-003 (GlobeNewswire) -6.61%
Mar-28-24 04:08PM	How Sleeper Biotech Solid Biosciences, With A 687% Gain, Is Making A Comeback (Investor's Business Daily) -6.53%
Mar-27-24 07:00AM	Solid Biosciences to Participate at Cantor's Virtual Muscular Dystrophy Symposium (GlobeNewswire) +5.01%
Mar-13-24 07:44AM	Solid Biosciences Provides Fourth Quarter and Full-Year 2023 Business Update and Financial Results (GlobeNewswire) +7.28%
Mar-07-24 07:00AM	Solid Biosciences Announces Licensing Agreement with Armatus Bio for the Use of AAV-SLB101, a Proprietary, Muscle-Targeted Capsid, in the Development of an RNAi Therapy to treat FSHD (GlobeNewswire) +7.86%
Mar-06-24 08:00AM	Solid Biosciences to Participate at Upcoming Investor Conferences (GlobeNewswire)
Feb-29-24 03:02AM	14 Stocks With Heavy Insider Buying In 2024 (Insider Monkey)
Jan-17-24 11:27AM	Solid Biosciences' (SLDB) DMD Drug Gets Orphan Tag, Stock Up (Zacks)
Jan-16-24 01:10PM	Hedge Fund and Insider Trading News: Anthony Scaramucci, Bill Ackman, Rokos Capital Management, ExodusPoint Capital, Alden Global Capital, Solid Biosciences Inc. (SLDB), and More (Insider Monkey)
08:00AM	Solid Biosciences Granted FDA Orphan Drug Designation for Duchenne Muscular Dystrophy Gene Therapy Candidate SGT-003 (GlobeNewswire)
Jan-15-24 10:18AM	Solid Biosciences (SLDB) Rises 271% in 3 Months: Here's Why (Zacks)
Jan-08-24 07:09AM	Solid Biosciences Announces $109 Million Private Placement (GlobeNewswire) +7.59%
Jan-04-24 08:00AM	Solid Biosciences to Participate at 42nd Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Dec-08-23 05:37AM	Solid Biosciences' (SLDB) DMD Drug Gets Fast Track Tag, Stock Up (Zacks) -12.15%
Dec-07-23 08:00AM	Solid Biosciences Receives FDA Fast Track Designation for Duchenne Muscular Dystrophy Gene Therapy SGT-003 (GlobeNewswire) +68.42%
Nov-22-23 08:00AM	Solid Biosciences to Participate at 35th Annual Piper Sandler Healthcare Conference (GlobeNewswire) +9.17%
Nov-16-23 08:29AM	Solid Biosciences (SLDB) Stock Up as FDA Clears DMD Drug IND (Zacks)
Nov-14-23 04:05PM	Solid Biosciences Announces IND Clearance by FDA for Duchenne Muscular Dystrophy Gene Therapy Candidate SGT-003 (GlobeNewswire) +27.93%
Nov-09-23 08:00AM	Solid Biosciences to Participate at Jefferies London Healthcare Conference (GlobeNewswire) -23.66%
Nov-08-23 04:17PM	Solid Biosciences Provides Third Quarter Business Update and Financial Results (GlobeNewswire)
Oct-02-23 08:00AM	Solid Biosciences Appoints Gabriel Brooks, M.D., as Chief Medical Officer (GlobeNewswire)
Sep-20-23 08:00AM	Solid Biosciences to Participate at Upcoming Investor Conferences (GlobeNewswire)
Sep-05-23 08:56AM	Solid Biosciences to Participate at Upcoming Investor Conferences (GlobeNewswire)
Aug-31-23 08:00AM	Solid Biosciences to Participate in Citis 18th Annual BioPharma Conference (GlobeNewswire)
Aug-14-23 04:17PM	Solid Biosciences Provides Second Quarter Business Update and Financial Results (GlobeNewswire)
Jun-01-23 08:00AM	Solid Biosciences to Participate at the Jefferies Healthcare Conference (GlobeNewswire)
May-22-23 08:00AM	Solid Biosciences to Participate at the Barclays Gene Editing & Therapy Summit (GlobeNewswire)
May-16-23 08:00AM	Solid Biosciences to Present at the American Society of Gene and Cell Therapy Annual Meeting (GlobeNewswire)
May-11-23 09:35AM	Solid Biosciences Inc. (SLDB) Reports Q1 Loss, Misses Revenue Estimates (Zacks)
07:30AM	Solid Biosciences Provides First Quarter Business Update and Financial Results (GlobeNewswire)
May-08-23 04:05PM	Solid Biosciences to Present at JMP Securities Life Sciences Conference (GlobeNewswire) +9.80%
Apr-21-23 08:00AM	Solid Biosciences to Participate in Chardans 7th Annual Genetic Medicines and Cell Therapy Manufacturing Summit (GlobeNewswire)
Apr-20-23 10:03AM	Will Alnylam Pharmaceuticals (ALNY) Report Negative Q1 Earnings? What You Should Know (Zacks)
Apr-19-23 10:01AM	Will Solid Biosciences Inc. (SLDB) Report Negative Q1 Earnings? What You Should Know (Zacks)
Apr-13-23 08:00AM	Solid Biosciences to Present at the 22nd Annual Needham Healthcare Conference (GlobeNewswire)
Mar-25-23 09:44AM	Solid Biosciences Full Year 2022 Earnings: EPS Misses Expectations (Simply Wall St.)
Mar-23-23 08:00AM	Solid Biosciences Provides Fourth Quarter and Full-Year 2022 Business Update and Financial Results (GlobeNewswire)
Mar-21-23 08:00AM	Solid Biosciences to Participate at BMO Biopharma Spotlight Series: Genetic Medicine Delivery (GlobeNewswire)
Mar-07-23 08:00AM	Solid Biosciences to Present at Barclays Global Healthcare Conference (GlobeNewswire) +5.01%
Mar-02-23 07:52AM	Solid Biosciences Inc.'s (NASDAQ:SLDB) 14% loss last week hit both individual investors who own 51% as well as institutions (Simply Wall St.)
Feb-08-23 08:00AM	Solid Biosciences to Present at SVB Securities Global Biopharma Conference (GlobeNewswire) -5.67%
Jan-26-23 08:00AM	Pathway Development Consortium Announces Publication in Human Gene Therapy on the Application of FDAs Accelerated Approval Pathway for AAV Gene Therapies for Patients with Duchenne Muscular Dystrophy (GlobeNewswire)
Jan-11-23 08:00AM	Solid Biosciences and Phlox Therapeutics Announce Strategic Research Collaboration Focused on Accelerating the Development of New Therapies for Rare Cardiac Diseases (GlobeNewswire) +5.04%

Solid Biosciences, Inc. is a life science company, which engages in the development of treatments for patients with Duchenne muscular dystrophy. It also focuses on developing treatments for neuromuscular and cardiac diseases. The company was founded by Ilan Ganot, Andrey J. Zarur, Matthew Bennett Arnold, Annie Ganot, and Gilad David Hayeem in March 2013 and is headquartered in Charlestown, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Kahn Clare	Director	Mar 11 '25	Buy	5.34	1,860	9,924	2,960	Mar 13 04:05 PM
Bain Capital Life Sciences Inv	10% Owner	Feb 19 '25	Buy	4.03	1,000,000	4,030,000	5,034,582	Feb 21 05:48 PM
PERCEPTIVE ADVISORS LLC	Director	Feb 19 '25	Buy	4.03	5,000,000	20,150,000	11,833,539	Feb 21 04:17 PM
Adage Capital Management, L.P.	10% Owner	Feb 18 '25	Buy	7.56	252,545	1,909,240	4,248,084	Feb 19 04:16 PM
Hanrahan Jessie	Chief Regulatory Officer	Feb 14 '25	Sale	3.96	3,079	12,193	19,281	Feb 18 04:05 PM
Brooks Gabriel	Chief Medical Officer	Feb 14 '25	Sale	3.96	3,256	12,894	22,812	Feb 18 04:05 PM
Tan Kevin	CFO & Treasurer	Feb 14 '25	Sale	3.96	3,164	12,529	32,250	Feb 18 04:05 PM
Howton David T	Chief Operating Officer	Feb 14 '25	Sale	3.96	5,561	22,022	24,789	Feb 18 04:05 PM
Herzich Paul	Chief Technology Officer	Feb 14 '25	Sale	3.96	2,688	10,644	18,388	Feb 18 04:05 PM
Cumbo Alexander	President and CEO	Feb 14 '25	Sale	3.96	11,365	45,005	60,717	Feb 18 04:05 PM
Ganot Ilan	Director	Feb 14 '25	Sale	3.96	1,711	6,776	14,839	Feb 18 04:05 PM
Howton David T	Officer	Feb 14 '25	Proposed Sale	3.96	5,561	22,022		Feb 14 05:25 PM
Herzich Paul	Officer	Feb 14 '25	Proposed Sale	3.96	2,688	10,644		Feb 14 05:25 PM
Tan Kevin	Officer	Feb 14 '25	Proposed Sale	3.96	3,164	12,529		Feb 14 05:23 PM
Cumbo Alexander	Officer	Feb 14 '25	Proposed Sale	3.96	11,365	45,005		Feb 14 05:23 PM
Hanrahan Jessie	Officer	Feb 14 '25	Proposed Sale	3.96	3,079	12,193		Feb 14 05:20 PM
Ganot Ilan	Director	Jan 28 '25	Sale	3.11	144	448	11,689	Jan 29 06:14 PM
Tan Kevin	CFO & Treasurer	Jan 10 '25	Sale	3.89	4,073	15,849	24,789	Jan 13 06:51 PM
Ganot Ilan	Director	Jan 06 '25	Sale	4.31	1,056	4,551	11,445	Jan 07 05:29 PM
Hanrahan Jessie	Chief Regulatory Officer	Dec 03 '24	Sale	5.60	4,610	25,822	14,235	Dec 04 05:34 PM
Howton David T	Officer	Dec 03 '24	Proposed Sale	5.60	5,072	28,396		Dec 04 05:33 PM
Cumbo Alexander	President and CEO	Dec 03 '24	Sale	5.60	11,114	62,236	38,484	Dec 04 05:27 PM
Howton David T	Chief Operating Officer	Dec 03 '24	Sale	5.60	5,072	28,396	15,663	Dec 04 05:04 PM
Herzich Paul	Chief Technology Officer	Dec 03 '24	Sale	5.60	2,777	15,551	12,182	Dec 04 04:42 PM
Cumbo Alexander	Officer	Dec 03 '24	Proposed Sale	5.79	10,687	61,878		Dec 03 05:35 PM
Brooks Gabriel	Chief Medical Officer	Oct 21 '24	Sale	6.50	2,923	19,000	10,979	Oct 22 04:05 PM
Kahn Clare	Director	Jun 07 '24	Buy	7.67	1,100	8,442	1,100	Jun 11 02:15 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

SLDB

Solid Biosciences Inc

Upgrade your FINVIZ experience